ConductScience.org, home

Paper34680554

Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine.

Carrasco-Hernández L and 5 others. Biomedicines, 2021. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Papers, record 34680554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34680554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine.
PubMed
Journal
Biomedicines
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.92
iCite
Revised in PubMed
2024-04-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carrasco-Hernández LLaura
2Quintana-Gallego EEsther
3Calero CCarmen
4Reinoso-Arija RRocío
5Ruiz-Duque BBorja
6López-Campos JLJosé Luishttps://orcid.org/0000-0003-1703-1367

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134028270Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.J Med Chem2021https://conductscience.org/library/papers/34028270PubMed
27543698CFTR as a cAMP-dependent regulator of sodium channels.Science1995https://conductscience.org/library/papers/7543698PubMed
326028628An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.Eur Respir Rev2015https://conductscience.org/library/papers/26028628PubMed
432554756CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways.Eur Respir Rev2020https://conductscience.org/library/papers/32554756PubMed
524040746Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.Am J Respir Crit Care Med2013https://conductscience.org/library/papers/24040746PubMed
629750581CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease.Expert Rev Respir Med2018https://conductscience.org/library/papers/29750581PubMed
712396422Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction.J Aerosol Med2002https://conductscience.org/library/papers/12396422PubMed
821658649Recommendations for the classification of diseases as CFTR-related disorders.J Cyst Fibros2011https://conductscience.org/library/papers/21658649PubMed
931344409Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.Steroids2019https://conductscience.org/library/papers/31344409PubMed
1015463907High frequency of the R75Q CFTR variation in patients with chronic obstructive pulmonary disease.J Cyst Fibros2004https://conductscience.org/library/papers/15463907PubMed
1124568560Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease.Respir Res2014https://conductscience.org/library/papers/24568560PubMed
122475911Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.Science1989https://conductscience.org/library/papers/2475911PubMed
1324106801Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.Am J Respir Cell Mol Biol2014https://conductscience.org/library/papers/24106801PubMed
1427561233Nano-based rescue of dysfunctional autophagy in chronic obstructive lung diseases.Expert Opin Drug Deliv2017https://conductscience.org/library/papers/27561233PubMed
1534379371Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease.Chronic Obstr Pulm Dis2021https://conductscience.org/library/papers/34379371PubMed
1628006950
Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.
Antioxid Redox Signal2017https://conductscience.org/library/papers/28006950PubMed
1733935699Cystic Fibrosis Lung Disease in the Aging Population.Front Pharmacol2021https://conductscience.org/library/papers/33935699PubMed
1825794013Second-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-rafts.PLoS One2015https://conductscience.org/library/papers/25794013PubMed
1926637637Augmentation of CFTR maturation by S-nitrosoglutathione reductase.Am J Physiol Lung Cell Mol Physiol2016https://conductscience.org/library/papers/26637637PubMed
2022903797Reactive oxygen species: from health to disease.Swiss Med Wkly2012https://conductscience.org/library/papers/22903797PubMed

See all 76 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
41055920Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR.Sci Prog2025https://conductscience.org/library/papers/41055920PubMed
38377145Assessment of functional diversities in patients with Asthma, COPD, Asthma-COPD overlap, and Cystic Fibrosis (CF).PLoS One2024https://conductscience.org/library/papers/38377145PubMed
37437299Icenticaftor, Novel Therapy for COPD: This Glass Is Half Full.Am J Respir Crit Care Med2023https://conductscience.org/library/papers/37437299PubMed
37250046Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks.Front Microbiol2023https://conductscience.org/library/papers/37250046PubMed
36768629The COPD-Associated Polymorphism Impairs the CFTR Function to Suppress Excessive IL-8 Production upon Environmental Pathogen Exposure.Int J Mol Sci2023https://conductscience.org/library/papers/36768629PubMed
35203708Chronic Obstructive Pulmonary Disease: The Present and Future.Biomedicines2022https://conductscience.org/library/papers/35203708PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADH5128PubTator's text mininghttps://conductscience.org/library/genes/128NCBI Gene
CAT847PubTator's text mininghttps://conductscience.org/library/genes/847NCBI Gene
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
PDE4A5141PubTator's text mininghttps://conductscience.org/library/genes/5141NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34680554

GET https://conductscience.org/api/papers/v1/34680554/references?page=2